180 related articles for article (PubMed ID: 3332162)
21. Depletion of T lymphocytes from human bone marrow. Use of magnetic monosized polymer microspheres coated with T-lymphocyte-specific monoclonal antibodies.
Vartdal F; Kvalheim G; Lea TE; Bosnes V; Gaudernack G; Ugelstad J; Albrechtsen D
Transplantation; 1987 Mar; 43(3):366-71. PubMed ID: 3103274
[TBL] [Abstract][Full Text] [Related]
22. Etoposide as an in vitro purging agent for the treatment of acute leukemias and lymphomas in conjunction with autologous bone marrow transplantation.
Ciobanu N; Paietta E; Andreeff M; Papenhausen P; Wiernik PH
Exp Hematol; 1986 Aug; 14(7):626-35. PubMed ID: 3525202
[TBL] [Abstract][Full Text] [Related]
23. Preliminary clinical trial of autologous bone marrow transplantation after in vitro monoclonal antibody and complement treatments in null cell-type acute lymphocytic leukemia.
Morishima Y; Sao H; Ueda R; Morishita Y; Murase T; Kodera Y; Ohno R; Tahara T; Yoshikawa S; Kato Y
Jpn J Cancer Res; 1985 Dec; 76(12):1222-9. PubMed ID: 3937834
[TBL] [Abstract][Full Text] [Related]
24. Magnetic microspheres and monoclonal antibodies for the depletion of neuroblastoma cells from bone marrow: experiences, improvements and observations.
Kemshead JT; Heath L; Gibson FM; Katz F; Richmond F; Treleaven J; Ugelstad J
Br J Cancer; 1986 Nov; 54(5):771-8. PubMed ID: 3542005
[TBL] [Abstract][Full Text] [Related]
25. Reduction of marrow hematopoietic progenitor and stem cell content is not sufficient for enhanced syngeneic engraftment.
Robinson S; van Os R; Sheridan T; Mauch P
Stem Cells; 2000; 18(2):93-101. PubMed ID: 10742381
[TBL] [Abstract][Full Text] [Related]
26. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC
Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
[TBL] [Abstract][Full Text] [Related]
27. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
28. Successful autologous transplantation of immunomagnetic bead purged bone marrow in non-Hodgkin's lymphoma.
Ogniben E; Hohaus S; Kvalheim G; Dörken B; Haas R
Prog Clin Biol Res; 1992; 377():189-95. PubMed ID: 1438415
[No Abstract] [Full Text] [Related]
29. Monoclonal antibody-purged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia at high risk of relapse.
Soiffer RJ; Roy DC; Gonin R; Murray C; Anderson KC; Freedman AS; Rabinowe SN; Robertson MJ; Spector N; Pesek K
Bone Marrow Transplant; 1993 Sep; 12(3):243-51. PubMed ID: 8241984
[TBL] [Abstract][Full Text] [Related]
30. [Evaluation of a modified immunomagnetic procedure for the purging of neuroblastoma cells from bone marrow].
Kremens B; Combaret V; Favrot MC; Laurent JC; Philip T
Monatsschr Kinderheilkd; 1990 Jun; 138(6):331-6. PubMed ID: 2197550
[TBL] [Abstract][Full Text] [Related]
31. A technique for isolation of bone marrow cells using hydroxyethyl starch (HES) sedimentation agent.
Montuoro A; De Rosa L; Del Monte C; Blandino F; Pandolfi A; Lanti T; De Laurenzi A
Haematologica; 1991 Mar; 76 Suppl 1():7-9. PubMed ID: 1713876
[TBL] [Abstract][Full Text] [Related]
32. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
De Rosa L; Lalle M; Pandolfi A; Ruscio C; Amodeo R
Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539
[TBL] [Abstract][Full Text] [Related]
33. Immunomagnetic microsphere mediated purging of cALLa positive leukemic cells from bone marrow for autologous reinfusion.
Janssen WE; Lee C; Johnson KS; Spencer C; Rios AM; Graham-Pole JR; Gross S
Prog Clin Biol Res; 1990; 333():285-92. PubMed ID: 2137931
[TBL] [Abstract][Full Text] [Related]
34. Purging of small cell lung cancer cells from bone marrow using immunomagnetic beads and a flow-through device.
Ball ED; Powers FJ; Vredenburgh JJ; Heath CA; Converse AO
Bone Marrow Transplant; 1991 Jul; 8(1):35-40. PubMed ID: 1655139
[TBL] [Abstract][Full Text] [Related]
35. Depletion of neuroblastoma cells from bone marrow with monoclonal antibodies and magnetic immunobeads.
Seeger RC; Reynolds CP; Vo DD; Ugelstad J; Wells J
Prog Clin Biol Res; 1985; 175():443-58. PubMed ID: 3887429
[No Abstract] [Full Text] [Related]
36. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.
Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE
Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119
[TBL] [Abstract][Full Text] [Related]
37. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.
Van Epps DE; Bender J; Lee W; Schilling M; Smith A; Smith S; Unverzagt K; Law P; Burgess J
Blood Cells; 1994; 20(2-3):411-23. PubMed ID: 7538347
[TBL] [Abstract][Full Text] [Related]
38. Relative efficiency of leukemic cell depletion using anti-murine-IgG1(Fc) or anti-murine-IgG coated immunomagnetic microbeads.
Janssen WE; Johnson KS; Lee C; Cassano W
Bone Marrow Transplant; 1990 Jan; 5(1):19-22. PubMed ID: 2297587
[TBL] [Abstract][Full Text] [Related]
39. Removal of neuroblastoma cells from bone marrow with monoclonal antibodies and magnetic immunobeads.
Seeger RC; Vo DD; Ugelstad J; Reynolds CP
Prog Clin Biol Res; 1986; 211():285-93. PubMed ID: 3515362
[No Abstract] [Full Text] [Related]
40. Removal of neuroblastoma cells from bone marrow with monoclonal antibodies conjugated to magnetic microspheres.
Treleaven JG; Gibson FM; Ugelstad J; Rembaum A; Philip T; Caine GD; Kemshead JT
Lancet; 1984 Jan; 1(8368):70-3. PubMed ID: 6140424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]